(NASDAQ: ZLAB) Zai Lab's forecast annual revenue growth rate of 38.3% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 138.45%, and while it is forecast to beat the US market's average forecast revenue growth rate of 9.82%.
Zai Lab's revenue in 2025 is $418,326,000.On average, 4 Wall Street analysts forecast ZLAB's revenue for 2025 to be $609,217,100,885, with the lowest ZLAB revenue forecast at $604,202,330,020, and the highest ZLAB revenue forecast at $613,639,601,602. On average, 4 Wall Street analysts forecast ZLAB's revenue for 2026 to be $836,582,668,172, with the lowest ZLAB revenue forecast at $775,591,859,900, and the highest ZLAB revenue forecast at $909,449,252,224.
In 2027, ZLAB is forecast to generate $1,173,856,652,843 in revenue, with the lowest revenue forecast at $1,162,661,011,464 and the highest revenue forecast at $1,185,052,294,222.